Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations

PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 11, 2017

Study Completion Date

December 31, 2020

Conditions
Chronic Rhinosinusitis
Interventions
DRUG

oral levofloxacin

DRUG

nebulized levofloxacin

Trial Locations (1)

14642

University of Rochester Department of Otolaryngology Head and Neck Surgery, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER

NCT01988779 - Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations | Biotech Hunter | Biotech Hunter